PDCD1 and pulmonary fibrosis: Importantly, clinical evidence and animal experimental studies have shown that neutralizing antibodies, Western medicine, and traditional Chinese medicine slow down pulmonary fibrosis by regulating signaling pathways such as Wnt/β-catenin signaling, the immune balance of cell subsets such as Th1 and Th2, and receptors such as PD-1.